Phase II Trial of RAD001 (Everolimus) in Previously Treated Small Cell Lung Cancer

Clinical trial NCT00374140 · COMPLETED

Trial details

NCT number: NCT00374140
Sponsor: Ahmad Tarhini
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Small Cell Lung Cancer

Start date: 2006-10-01
Primary completion: 2008-12-01
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.